(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

MÉTODO PARA TRATAR UM CÂNCER, E, COMPOSIÇÃO

Em AnáliseInvention PatentPCT · US2022025420

Application data

Number

112023021665

Type

Invention Patent

Filing

04/19/2022

Publication

12/19/2023

PCT

US2022025420

Progress at the INPI

  1. Filing04/19/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 04/19/2022. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 12/19/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

IOVANCE BIOTHERAPEUTICS, INC.

US

See this company's full portfolio

Inventors

F. V. (pessoa física)

US

R. C. (pessoa física)

US

Y. Z. (pessoa física)

US

Technical data

Priority claims

US

63/176,675 · 04/19/2021

US

63/223,925 · 07/20/2021

US

63/254,297 · 10/11/2021

US

63/284,177 · 11/30/2021

Abstract

A presente invenção provê composições compreendendo receptores quiméricos, incluindo receptores coestimulatórios quiméricos (CCRs) e/ou receptores de quimiocina, métodos para preparar CCRs e/ou receptores de quimiocina e populações terapêuticas de linfócitos infiltrantes tumorais, linfócitos infiltrantes medulares e linfócitos do sangue periférico expressando CCRs e/ou receptores de quimiocina com desempenho terapêutico aumentado e outras vantagens para o tratamento de cânceres, incluindo cânceres de tumor sólido.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

12/19/2023

RPI 2763

Alteração de dados cadastrais

#1.1

10/31/2023

RPI 2756

Related

From the same holder

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.